About MESOGEN INC.
Mesogen is a biotechnology company focused on advancing patient-derived regenerative medicine, specifically targeting curative treatments for macular degeneration and Type 1 diabetes through autologous cell therapy. The company is headquartered in the Woodlands, Texas.
Development of autologous engineered Retinal Pigment Epithelium (RPE) cell patches for transplantInvestigation of patient-derived insulin-producing beta-like cells for diabetes treatmentProprietary, time-bound cell engineering processesTissue engineering innovations for regenerative medicine
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to MESOGEN INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.